• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher Richard Anzalone

Location
Pasadena, CA
Summary
The estimated net worth of Christopher Richard Anzalone is at least $251,799,942 dollars as of 05 Jan 2026. Christopher Richard Anzalone is the Chief Executive Officer, Director of ARROWHEAD PHARMACEUTICALS, INC. and owns shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) stock worth about $251.8M.
Signature
/s/Christopher Anzalone
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Richard Anzalone and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Christopher Richard Anzalone has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $251,799,942.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ARROWHEAD PHARMACEUTICALS, INC. ($251,799,942).
  • Past-year value change for that position: -$25,543,901.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Richard Anzalone

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARWR ARROWHEAD PHARMACEUTICALS, INC. Chief Executive Officer, Director $251,799,942 -$25,543,901 -9.2% 02 Jan 2026

Insider Transactions Reported by Christopher Richard Anzalone:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored